Pharmalyte Solutions LLC
2 clinical trials · Sponsor
◉ Watch Pharmalyte Solutions LLC
| Record | Firm | Date |
|---|---|---|
| MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus (NCT03567824) | Pharmalyte Solutions LLC | 2026-03-01 |
| MLD10 in the Prevention of Migraine in Adults (NCT02322333) | Pharmalyte Solutions LLC | 2015-03-01 |
Track Pharmalyte Solutions LLC automatically
Every clearance here is in the API, with alerts when new ones post.